Clinical Trial Update: Efficacy of Olibra: A 12 Week Controlled Trial [Phase 1, Phase 2]

View source ↗

Summary

A completed 12-week controlled Phase 1/2 trial evaluating the efficacy of Olibra in adults with overweight or obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Olibra

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Overweight, Obesity | Phase 1, Phase 2 | Status: COMPLETED